(Q45690180)

English

Adjuvant hepatic intra-arterial iodine-131-lipiodol following curative resection of hepatocellular carcinoma: a prospective randomized trial

scientific article published in June 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Adjuvant hepatic intra-arterial iodine-131-lipiodol following curative resection of hepatocellular carcinoma: a prospective randomized trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

author name string

A Y F Chung

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

L L P J Ooi

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

D Machin

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

S B Tan

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

B K P Goh

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

J S Wong

6

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Y M Chen

7

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

P C N Li

8

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

M Gandhi

9

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

C H Thng

10

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

S W K Yu

11

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

B S Tan

12

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

R H G Lo

13

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

A M M Htoo

14

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

K H Tay

15

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

F X Sundram

16

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

A S W Goh

17

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

S P Chew

18

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

K H Liau

19

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

K H Tay

21

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Y M Tan

22

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

P C Cheow

23

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

C K Ho

24

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

K C Soo

25

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

publication date

1 June 2013

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

World Journal of Surgery

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

37

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

1356-1361

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-1970-4

21 January 2018

Outcomes and recurrence of initially resectable hepatocellular carcinoma meeting milan criteria: Rationale for partial hepatectomy as first strategy.

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-1970-4

21 January 2018

Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-1970-4

21 January 2018

Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-1970-4

21 January 2018

Trials stopped early: too good to be true?

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-1970-4

21 January 2018

Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-1970-4

21 January 2018

Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-1970-4

21 January 2018

Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-1970-4

21 January 2018

Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23463394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal

1 reference

https://pubmed.ncbi.nlm.nih.gov/23463394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23463394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant intra-arterial injection of iodine-131-labeled lipiodol after resection of hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23463394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dosimetry of iodine-131 ethiodol in the treatment of hepatoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23463394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/23463394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23463394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23463394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rationale of surgical management for recurrent hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23463394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00268-013-1970-4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45690180&oldid=2207269186"